Join
Live feed
·
INSIDERFilingvia Quantisnow
Concert Pharmaceuticals Inc. logo

SEC Form 4: Cassella James V sold $84,385 worth of shares (10,106 units at $8.35) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 176,823 units (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.
CNCE· Concert Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNCE (Concert Pharmaceuticals Inc.) and more on Quantisnow.